← Leaderboards
Mrinal Gounder
Sloan-Kettering Inst Can Research
$874,732
Attributed
$874,732
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $286.4K · FY2015–18$500K$375K$250K$125K$0
'15
'16
'17
'18
Funding mix
By agency
FDA$874,732 · 1
By mechanism
R01$874,732 · 1
Top collaborators
No co-investigators on record.
Grant awards (4)
Phase III Randomized Blinded Trial of Sorafenib vs Placebo in Desmoid Tumor A091105/116279 12/2013$153,278
R01 · FY2018 · FD · contact PI
Phase III Randomized Blinded Trial of Sorafenib vs Placebo in Desmoid Tumor A091105/116279 12/2013$284,221
R01 · FY2017 · FD · contact PI
Phase III Randomized Blinded Trial of Sorafenib vs Placebo in Desmoid Tumor A091105/116279 12/2013$286,378
R01 · FY2016 · FD · contact PI
Phase III Randomized Blinded Trial of Sorafenib vs Placebo in Desmoid Tumor A091105/116279 12/2013$150,855
R01 · FY2015 · FD · contact PI